Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 65
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 19
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Diabetic Gastroparesis 33
May 10, 2017: Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 33
May 03, 2017: EndoLogic Announces Scheduling of pre-IND Meeting with FDA to Discuss Renzapride in Diabetic Gastroparesis 33
May 01, 2017: Allergan to Present Data on Relamorelin at Digestive Disease Week 2017 33
Clinical Trial Profile Snapshots 35
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Source 65

List of Tables
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2017* 7
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 16
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 20
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11
Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 19
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
GlobalData Methodology 64
Filed in: Pharmaceutical
Publisher : GlobalData